As the tremendously contagious Omicron variant continues to propel its way through the world, the youngest generation of the population will be able to get the Covid-19 vaccination even sooner than expected. Pfizer board member and previous commissioner of the FDA, Scott Gottlieb, stated on Sunday that the vaccine is likely to be approved by March. Pfizer-BioNTech is seeking approval from the United States Food and Drug Administration to sanction a Covid-19 vaccine directed for the more than 19 million children in the United States under 5 years old in a two-dose process as continual research on the benefits of three doses is published.